Betmakers Technology Group Ltd
ASX:BET
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Betmakers Technology Group Ltd
ASX:BET
|
AU |
|
N
|
NEPI Rockcastle PLC
LSE:0RU4
|
IM |
|
Z
|
Zhejiang Anglikang Pharmaceutical Co Ltd
SZSE:002940
|
CN |
Balance Sheet
Balance Sheet Decomposition
Betmakers Technology Group Ltd
Betmakers Technology Group Ltd
Balance Sheet
Betmakers Technology Group Ltd
| Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
2
|
3
|
1
|
0
|
32
|
121
|
88
|
41
|
15
|
19
|
|
| Cash |
0
|
0
|
0
|
2
|
3
|
1
|
0
|
32
|
121
|
88
|
41
|
15
|
19
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
2
|
5
|
1
|
2
|
9
|
15
|
28
|
14
|
13
|
|
| Accounts Receivables |
0
|
0
|
0
|
1
|
2
|
5
|
0
|
1
|
8
|
10
|
14
|
10
|
9
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
5
|
14
|
4
|
4
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
4
|
4
|
3
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
4
|
5
|
16
|
14
|
|
| Total Current Assets |
1
|
0
|
0
|
4
|
5
|
7
|
2
|
34
|
135
|
109
|
75
|
49
|
49
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
14
|
30
|
33
|
27
|
17
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
14
|
30
|
33
|
27
|
17
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
5
|
7
|
13
|
22
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
6
|
3
|
7
|
6
|
24
|
35
|
26
|
28
|
29
|
|
| Goodwill |
4
|
0
|
4
|
4
|
0
|
0
|
14
|
14
|
44
|
31
|
31
|
31
|
31
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
2
|
4
|
5
|
7
|
7
|
12
|
19
|
35
|
15
|
8
|
|
| Other Assets |
4
|
0
|
4
|
4
|
0
|
0
|
14
|
14
|
44
|
31
|
31
|
31
|
31
|
|
| Total Assets |
5
N/A
|
0
N/A
|
0
N/A
|
11
N/A
|
15
+42%
|
16
+5%
|
31
+92%
|
63
+105%
|
230
+268%
|
223
-3%
|
200
-11%
|
151
-25%
|
134
-11%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
0
|
1
|
1
|
2
|
4
|
3
|
1
|
1
|
10
|
3
|
4
|
5
|
7
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
4
|
8
|
15
|
14
|
14
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
2
|
0
|
6
|
0
|
8
|
10
|
25
|
17
|
17
|
|
| Total Current Liabilities |
2
|
2
|
1
|
2
|
6
|
3
|
7
|
2
|
22
|
21
|
45
|
37
|
38
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
5
|
3
|
2
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
11
|
8
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
6
+160%
|
3
-48%
|
11
+259%
|
2
-81%
|
35
+1 492%
|
34
-3%
|
49
+45%
|
39
-20%
|
39
0%
|
|
| Equity | ||||||||||||||
| Common Stock |
3
|
0
|
0
|
15
|
23
|
32
|
42
|
85
|
226
|
252
|
300
|
305
|
321
|
|
| Retained Earnings |
0
|
0
|
0
|
6
|
14
|
20
|
23
|
25
|
31
|
63
|
149
|
194
|
226
|
|
| Total Equity |
3
N/A
|
0
N/A
|
0
N/A
|
8
N/A
|
9
+8%
|
13
+41%
|
19
+50%
|
60
+215%
|
195
+224%
|
189
-3%
|
151
-20%
|
112
-26%
|
95
-15%
|
|
| Total Liabilities & Equity |
5
N/A
|
0
N/A
|
0
N/A
|
11
N/A
|
15
+42%
|
16
+5%
|
31
+92%
|
63
+105%
|
230
+268%
|
223
-3%
|
200
-11%
|
151
-25%
|
134
-11%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
138
|
0
|
0
|
108
|
160
|
189
|
413
|
569
|
813
|
904
|
944
|
965
|
1 087
|
|